Baxter (NYSE:BAX) has issued a letter to affected customers recommending a correction for its Novum IQ infusion pump systems.

Glucotrack (Nasdaq:GCTK) today announced multiple developments in the timeline for its long-term continuous blood glucose monitor (CBGM).

ViCentra today announced its plans to kick off the launch of its next-generation hybrid closed-loop automated insulin delivery system.

One of the leaders in continuous glucose monitoring (CGM) technology, Dexcom (Nadsaq:DXCM) continues to expand its capabilities.

Medtronic announced today that it selected "MiniMed" as the name for its Diabetes unit following its planned separation.

Medtronic (NYSE:MDT) announced today that it intends to separate its Diabetes business into a new standalone company.

Sequel Med Tech and Senseonics today announced a commercial development agreement to combine insulin delivery and glucose monitoring systems.

Insulet (Nasdaq:PODD) announced today that the FDA cleared its Omnipod 5 automated insulin delivery for use by people with type 2 diabetes.

Abbott (NYSE:ABT) and Medtronic (NYSE:MDT) today announced a global partnership pairing Abbott CGMs with Medtronic insulin delivery systems.

Know Labs (NYSE:KNW) today unveiled KnowU, its wearable, non-invasive continuous glucose monitor (CGM) system.

Insulet (Nasdaq:PODD) today announced a duo of updates related to its Omnipod 5 system that includes a significant integration development.

Ypsomed announced today that Eli Lilly (NYSE:LLY) elected to stop their joint project to enter the U.S. insulin pump market.